Download presentation
Presentation is loading. Please wait.
Published byἘλιακείμ Αρβανίτης Modified over 5 years ago
1
My Treatment Approach to Hairy Cell Leukemia
Rahul R. Naik, MD, Alan Saven, MD Mayo Clinic Proceedings Volume 87, Issue 1, Pages (January 2012) DOI: /j.mayocp Copyright © 2012 Mayo Foundation for Medical Education and Research Terms and Conditions
2
FIGURE 1 Peripheral blood smear specimen showing circumferential cytoplasmic projections characteristic of hairy cell leukemia (Wright-Giemsa, original magnification ×1000). Photomicrograph courtesy of Robert W. Sharpe, MD, Department of Pathology, Scripps Clinic, La Jolla, CA. Mayo Clinic Proceedings , 67-76DOI: ( /j.mayocp ) Copyright © 2012 Mayo Foundation for Medical Education and Research Terms and Conditions
3
FIGURE 2 Bone marrow biopsy specimen from patient with hairy cell leukemia showing hypercellularity with hairy cells having nuclei widely separated by abundant cytoplasm, giving characteristic “fried egg” appearance (hematoxylin-eosin, original magnification ×600). Photomicrograph courtesy of Robert W. Sharpe, MD, Department of Pathology, Scripps Clinic, La Jolla, CA. Mayo Clinic Proceedings , 67-76DOI: ( /j.mayocp ) Copyright © 2012 Mayo Foundation for Medical Education and Research Terms and Conditions
4
FIGURE 3 Treatment algorithm. aCladribine preferred because of its ease of administration, favorable toxicity profile, and higher complete response rates. bIndicates consider switching to other purine analog given lack of cross-resistance. HCL = hairy cell leukemia. Mayo Clinic Proceedings , 67-76DOI: ( /j.mayocp ) Copyright © 2012 Mayo Foundation for Medical Education and Research Terms and Conditions
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.